Stephane Puyo
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Insights Into the Spatiotemporal Patterns of Complexity of Ventricular Fibrillation by Multilead Analysis of Body Surface Potential Maps.
Journal: Frontiers in physiology
Published: April 23, 2020
Noninvasive Mapping and Electrocardiographic Imaging in Atrial and Ventricular Arrhythmias (CardioInsight).
Journal: Cardiac electrophysiology clinics
Published: August 12, 2019
Post-Myocardial Infarction Scar With Fat Deposition Shows Specific Electrophysiological Properties and Worse Outcome After Ventricular Tachycardia Ablation.
Journal: Journal of the American Heart Association
Published: August 06, 2019
Cardiac Propagation Pattern Mapping With Vector Field for Helping Tachyarrhythmias Diagnosis With Clinical Tridimensional Electro-Anatomical Mapping Tools.
Journal: IEEE transactions on bio-medical engineering
Published: July 12, 2018
Mapping and Ablation of Idiopathic Ventricular Fibrillation.
Journal: Frontiers in cardiovascular medicine
Published: May 27, 2018
Atrial Fibrillation Mechanisms and Implications for Catheter Ablation.
Journal: Frontiers in physiology
Published: April 30, 2018
Noninvasive Assessment of Atrial Fibrillation Complexity in Relation to Ablation Characteristics and Outcome.
Journal: Frontiers in physiology
Published: March 29, 2018
Localized Structural Alterations Underlying a Subset of Unexplained Sudden Cardiac Death.
Journal: Circulation. Arrhythmia and electrophysiology
Published: October 04, 2017
Frontiers in non-invasive cardiac mapping: future implications for arrhythmia treatment.
Journal: Minerva cardioangiologica
Published: July 15, 2017
From old alkylating agents to new minor groove binders.
Journal: Critical reviews in oncology/hematology
Published: March 19, 2013
Gene expression signature predicting high-grade prostate cancer responses to oxaliplatin.
Journal: Molecular pharmacology
Published: September 19, 2012
The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
Journal: Molecular pharmacology
Published: April 25, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026